Greenwich LifeSciences, Inc. (GLSI) News
Track canonical SquawkNews coverage tagged to GLSI, Greenwich LifeSciences, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
FORM 4P GLSI - Greenwich LifeSciences, Inc.|DIRECTOR|OFFICER|10% OWNER - CEO and CFO: Patel SnehalP | 3,600 | $13.061 | $47,018
FORM 4P GLSI - Greenwich LifeSciences, Inc.|DIRECTOR|OFFICER|10% OWNER - CEO and CFO: Patel SnehalP | 3,600 | $13.061 | $47,018
EQUITY | Jul 27, 2026, 10:58 AM UTC
L
GLSI Greenwich Lifesciences announces approval to expand flamingo-01 into the United Kingdom
GLSI Greenwich Lifesciences announces approval to expand flamingo-01 into the United Kingdom
EQUITY | Jul 22, 2026, 10:35 AM UTC
L
GLSI +4% on Light volume following earlier PR: Greenwich Lifesciences Receives Approval From European Medicines Agency To Combine HLA-A*02,
GLSI +4% on Light volume following earlier PR: Greenwich Lifesciences Receives Approval From European Medicines Agency To Combine HLA-A*02, Non-HLA-A*02 Participants In Europe
EQUITY | Jul 16, 2026, 12:43 PM UTC